Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Migraine Disorders | 38 | 2024 | 1703 | 5.750 |
Why?
|
Stroke | 24 | 2023 | 9758 | 2.310 |
Why?
|
Brain Ischemia | 11 | 2022 | 3049 | 1.790 |
Why?
|
Cacao | 6 | 2024 | 98 | 1.730 |
Why?
|
Intracranial Hemorrhages | 5 | 2020 | 822 | 1.210 |
Why?
|
Activities of Daily Living | 8 | 2020 | 2421 | 1.100 |
Why?
|
Manipulation, Spinal | 3 | 2021 | 21 | 1.020 |
Why?
|
Migraine with Aura | 4 | 2021 | 204 | 1.010 |
Why?
|
Leukoencephalopathies | 2 | 2019 | 256 | 0.910 |
Why?
|
Restless Legs Syndrome | 2 | 2015 | 233 | 0.780 |
Why?
|
Cognition Disorders | 7 | 2015 | 3980 | 0.760 |
Why?
|
Recovery of Function | 5 | 2014 | 2979 | 0.750 |
Why?
|
Leukoaraiosis | 1 | 2022 | 116 | 0.750 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2021 | 1390 | 0.750 |
Why?
|
Chiropractic | 1 | 2020 | 39 | 0.720 |
Why?
|
Migraine without Aura | 3 | 2021 | 82 | 0.700 |
Why?
|
Disabled Persons | 4 | 2015 | 1226 | 0.670 |
Why?
|
Ischemic Attack, Transient | 3 | 2014 | 882 | 0.660 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 336 | 0.620 |
Why?
|
Headache | 3 | 2020 | 1256 | 0.610 |
Why?
|
Cardiovascular Diseases | 13 | 2024 | 15502 | 0.580 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2017 | 94 | 0.560 |
Why?
|
Dementia | 4 | 2016 | 2689 | 0.560 |
Why?
|
Headache Disorders | 2 | 2020 | 152 | 0.540 |
Why?
|
Alcohol Drinking | 3 | 2016 | 4028 | 0.540 |
Why?
|
Vitamins | 9 | 2024 | 1635 | 0.540 |
Why?
|
Spouses | 2 | 2016 | 283 | 0.530 |
Why?
|
beta 2-Microglobulin | 1 | 2017 | 329 | 0.530 |
Why?
|
Tai Ji | 3 | 2024 | 289 | 0.500 |
Why?
|
Triglycerides | 3 | 2019 | 2461 | 0.490 |
Why?
|
Exercise | 4 | 2024 | 5890 | 0.470 |
Why?
|
Prospective Studies | 21 | 2023 | 54423 | 0.460 |
Why?
|
Risk Factors | 33 | 2024 | 74213 | 0.450 |
Why?
|
Women's Health | 6 | 2023 | 2065 | 0.440 |
Why?
|
Depression | 5 | 2018 | 8126 | 0.430 |
Why?
|
Motor Activity | 2 | 2015 | 2715 | 0.430 |
Why?
|
Vitamin D | 3 | 2022 | 3303 | 0.430 |
Why?
|
Manipulation, Chiropractic | 2 | 2024 | 24 | 0.420 |
Why?
|
Aged | 41 | 2024 | 169310 | 0.410 |
Why?
|
Female | 65 | 2024 | 392705 | 0.400 |
Why?
|
Life Style | 3 | 2019 | 3917 | 0.400 |
Why?
|
Cardiology | 1 | 2023 | 1656 | 0.400 |
Why?
|
Cholesterol, LDL | 2 | 2019 | 2382 | 0.380 |
Why?
|
Middle Aged | 46 | 2024 | 220921 | 0.380 |
Why?
|
Arteritis | 2 | 2024 | 158 | 0.380 |
Why?
|
Hyperglycemia | 1 | 2020 | 1376 | 0.370 |
Why?
|
Humans | 89 | 2024 | 761596 | 0.370 |
Why?
|
Smoking | 5 | 2020 | 9053 | 0.370 |
Why?
|
Lipids | 3 | 2024 | 3341 | 0.360 |
Why?
|
Cohort Studies | 20 | 2024 | 41495 | 0.360 |
Why?
|
Randomized Controlled Trials as Topic | 12 | 2024 | 10212 | 0.340 |
Why?
|
Food Supply | 1 | 2015 | 544 | 0.340 |
Why?
|
Double-Blind Method | 8 | 2024 | 12341 | 0.330 |
Why?
|
Dietary Supplements | 10 | 2024 | 3415 | 0.330 |
Why?
|
Health Status | 2 | 2019 | 4077 | 0.320 |
Why?
|
Logistic Models | 7 | 2017 | 13255 | 0.310 |
Why?
|
Patient Admission | 1 | 2016 | 1367 | 0.310 |
Why?
|
Nursing Homes | 1 | 2016 | 1082 | 0.300 |
Why?
|
Rehabilitation | 2 | 2009 | 130 | 0.300 |
Why?
|
Hyperlipidemias | 2 | 2020 | 771 | 0.300 |
Why?
|
Pilot Projects | 6 | 2024 | 8633 | 0.290 |
Why?
|
Research Design | 3 | 2021 | 6180 | 0.290 |
Why?
|
Nurses | 4 | 2024 | 2478 | 0.280 |
Why?
|
Utilization Review | 1 | 2008 | 382 | 0.270 |
Why?
|
Cholesterol, HDL | 3 | 2020 | 1814 | 0.270 |
Why?
|
Cerebrovascular Disorders | 1 | 2013 | 1474 | 0.260 |
Why?
|
Myocardial Infarction | 4 | 2022 | 11461 | 0.240 |
Why?
|
Risk | 5 | 2019 | 9610 | 0.240 |
Why?
|
Incidence | 7 | 2021 | 21355 | 0.230 |
Why?
|
Male | 41 | 2024 | 360846 | 0.230 |
Why?
|
Plant Extracts | 3 | 2023 | 497 | 0.230 |
Why?
|
Oxylipins | 1 | 2024 | 53 | 0.230 |
Why?
|
Cognition | 5 | 2024 | 6992 | 0.230 |
Why?
|
Arthritis, Rheumatoid | 3 | 2024 | 3763 | 0.230 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2273 | 0.220 |
Why?
|
Aspirin | 2 | 2013 | 3133 | 0.220 |
Why?
|
Antirheumatic Agents | 2 | 2024 | 1373 | 0.220 |
Why?
|
Aged, 80 and over | 12 | 2020 | 58984 | 0.220 |
Why?
|
Odds Ratio | 7 | 2017 | 9647 | 0.210 |
Why?
|
Body Mass Index | 3 | 2017 | 12953 | 0.210 |
Why?
|
Neck Pain | 1 | 2024 | 190 | 0.210 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39106 | 0.210 |
Why?
|
France | 2 | 2015 | 497 | 0.200 |
Why?
|
Longitudinal Studies | 7 | 2017 | 14608 | 0.200 |
Why?
|
Health Surveys | 3 | 2019 | 4061 | 0.180 |
Why?
|
Yoga | 1 | 2024 | 281 | 0.180 |
Why?
|
Methotrexate | 2 | 2024 | 1719 | 0.180 |
Why?
|
Intermediate Filaments | 1 | 2021 | 172 | 0.170 |
Why?
|
Probability | 2 | 2017 | 2477 | 0.170 |
Why?
|
Hydroxychloroquine | 1 | 2024 | 426 | 0.170 |
Why?
|
Disability Evaluation | 3 | 2016 | 1836 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 4 | 2022 | 36426 | 0.160 |
Why?
|
Hypertension | 2 | 2020 | 8540 | 0.160 |
Why?
|
Apolipoprotein A-I | 1 | 2020 | 299 | 0.160 |
Why?
|
Integrative Medicine | 1 | 2020 | 87 | 0.150 |
Why?
|
Arteries | 1 | 2023 | 1123 | 0.150 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2010 | 324 | 0.150 |
Why?
|
Hemostasis | 1 | 2021 | 467 | 0.150 |
Why?
|
Memory Disorders | 2 | 2016 | 1199 | 0.150 |
Why?
|
Marital Status | 2 | 2016 | 426 | 0.140 |
Why?
|
Geriatric Assessment | 2 | 2016 | 1410 | 0.140 |
Why?
|
Education | 1 | 2020 | 537 | 0.140 |
Why?
|
Task Performance and Analysis | 1 | 2021 | 763 | 0.140 |
Why?
|
Case-Control Studies | 6 | 2021 | 22176 | 0.140 |
Why?
|
Diet | 1 | 2014 | 8075 | 0.130 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 26129 | 0.130 |
Why?
|
Neoplasms | 2 | 2022 | 22173 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 7 | 2021 | 17904 | 0.130 |
Why?
|
Muscle Contraction | 1 | 2021 | 1201 | 0.130 |
Why?
|
Polymorphism, Genetic | 3 | 2011 | 4243 | 0.130 |
Why?
|
Complementary Therapies | 1 | 2020 | 486 | 0.130 |
Why?
|
Gait | 1 | 2021 | 814 | 0.120 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1380 | 0.120 |
Why?
|
Accidental Falls | 1 | 2023 | 1068 | 0.120 |
Why?
|
Obesity | 2 | 2020 | 12947 | 0.120 |
Why?
|
Genome-Wide Association Study | 4 | 2021 | 12690 | 0.120 |
Why?
|
Widowhood | 1 | 2014 | 51 | 0.110 |
Why?
|
Drug Therapy, Combination | 1 | 2024 | 6312 | 0.110 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15843 | 0.110 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12059 | 0.110 |
Why?
|
Survivors | 2 | 2022 | 2371 | 0.110 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9032 | 0.110 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2017 | 487 | 0.110 |
Why?
|
Treatment Outcome | 8 | 2024 | 64685 | 0.110 |
Why?
|
Lower Extremity | 1 | 2021 | 1202 | 0.100 |
Why?
|
Cholesterol | 2 | 2012 | 2905 | 0.100 |
Why?
|
Aging | 1 | 2011 | 8710 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2020 | 15936 | 0.100 |
Why?
|
Mobility Limitation | 1 | 2016 | 408 | 0.100 |
Why?
|
Lymphotoxin-alpha | 1 | 2011 | 93 | 0.100 |
Why?
|
Comorbidity | 2 | 2017 | 10508 | 0.100 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3415 | 0.090 |
Why?
|
Adult | 13 | 2024 | 221210 | 0.090 |
Why?
|
Brain | 3 | 2022 | 27121 | 0.090 |
Why?
|
Prognosis | 3 | 2017 | 29629 | 0.090 |
Why?
|
Mendelian Randomization Analysis | 3 | 2021 | 1007 | 0.090 |
Why?
|
Diet Surveys | 1 | 2014 | 1162 | 0.090 |
Why?
|
Parkinson Disease | 1 | 2024 | 2877 | 0.090 |
Why?
|
Risk Assessment | 2 | 2023 | 23996 | 0.090 |
Why?
|
Psychological Tests | 1 | 2012 | 640 | 0.090 |
Why?
|
Bereavement | 1 | 2014 | 308 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5247 | 0.080 |
Why?
|
Neuropsychological Tests | 2 | 2014 | 7054 | 0.080 |
Why?
|
Organ Size | 1 | 2014 | 2254 | 0.080 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 276 | 0.080 |
Why?
|
Educational Status | 1 | 2016 | 2522 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2021 | 3462 | 0.080 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2009 | 362 | 0.070 |
Why?
|
Sex Factors | 3 | 2017 | 10554 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2018 | 2639 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5872 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4352 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3743 | 0.070 |
Why?
|
Vitamin E | 1 | 2010 | 872 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2016 | 2095 | 0.070 |
Why?
|
Estrogen Receptor alpha | 1 | 2010 | 583 | 0.060 |
Why?
|
United States | 7 | 2024 | 72340 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4948 | 0.060 |
Why?
|
Pain | 1 | 2021 | 5073 | 0.060 |
Why?
|
Self Report | 1 | 2017 | 3725 | 0.060 |
Why?
|
Receptors, Progesterone | 1 | 2010 | 1129 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8481 | 0.060 |
Why?
|
Memory | 1 | 2014 | 2193 | 0.060 |
Why?
|
Sulfasalazine | 1 | 2024 | 84 | 0.060 |
Why?
|
Poverty | 1 | 2015 | 2697 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13510 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1886 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15266 | 0.050 |
Why?
|
Pandemics | 1 | 2023 | 8656 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7828 | 0.050 |
Why?
|
Minerals | 1 | 2024 | 283 | 0.050 |
Why?
|
Patients | 1 | 2009 | 907 | 0.050 |
Why?
|
Fibrinopeptide A | 1 | 2021 | 43 | 0.050 |
Why?
|
Factor XI | 1 | 2021 | 34 | 0.050 |
Why?
|
Prothrombin Time | 1 | 2021 | 117 | 0.050 |
Why?
|
Factor VII | 1 | 2021 | 139 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2012 | 3826 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4878 | 0.040 |
Why?
|
Recurrence | 1 | 2013 | 8466 | 0.040 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 204 | 0.040 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2020 | 69 | 0.040 |
Why?
|
Prevalence | 2 | 2014 | 15733 | 0.040 |
Why?
|
Integrin beta Chains | 1 | 2020 | 115 | 0.040 |
Why?
|
Vasculitis | 1 | 2024 | 521 | 0.040 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2021 | 277 | 0.040 |
Why?
|
Attitude to Health | 1 | 2009 | 2025 | 0.040 |
Why?
|
Health Personnel | 2 | 2014 | 3335 | 0.040 |
Why?
|
Genotype | 4 | 2021 | 12990 | 0.040 |
Why?
|
International Normalized Ratio | 1 | 2021 | 382 | 0.040 |
Why?
|
Postural Balance | 1 | 2023 | 622 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2021 | 422 | 0.040 |
Why?
|
Factor VIII | 1 | 2021 | 348 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8601 | 0.040 |
Why?
|
Epilepsy | 1 | 2013 | 3290 | 0.040 |
Why?
|
Young Adult | 2 | 2023 | 59260 | 0.040 |
Why?
|
Quality of Life | 2 | 2018 | 13367 | 0.040 |
Why?
|
Fibrinogen | 1 | 2021 | 888 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2021 | 673 | 0.040 |
Why?
|
Lipoproteins | 1 | 2021 | 881 | 0.030 |
Why?
|
Adolescent | 2 | 2023 | 88326 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12463 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1164 | 0.030 |
Why?
|
Qualitative Research | 2 | 2021 | 3025 | 0.030 |
Why?
|
Telomerase | 1 | 2020 | 745 | 0.030 |
Why?
|
Executive Function | 1 | 2023 | 1392 | 0.030 |
Why?
|
Intelligence | 1 | 2020 | 924 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21019 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3889 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 2020 | 981 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2022 | 1819 | 0.030 |
Why?
|
Gene Frequency | 2 | 2011 | 3606 | 0.030 |
Why?
|
Mice | 1 | 2020 | 81539 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1590 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2020 | 1315 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2024 | 8527 | 0.030 |
Why?
|
Independent Living | 1 | 2016 | 579 | 0.020 |
Why?
|
Pain Measurement | 1 | 2021 | 3551 | 0.020 |
Why?
|
Receptors, FSH | 1 | 2010 | 29 | 0.020 |
Why?
|
Health Promotion | 1 | 2022 | 2214 | 0.020 |
Why?
|
Aromatase | 1 | 2010 | 147 | 0.020 |
Why?
|
Estrogen Receptor beta | 1 | 2010 | 168 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2021 | 3688 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2016 | 2696 | 0.020 |
Why?
|
Animals | 1 | 2020 | 168475 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12149 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2879 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18399 | 0.020 |
Why?
|
Contraceptives, Oral | 1 | 2009 | 554 | 0.020 |
Why?
|
Brain Chemistry | 1 | 2010 | 960 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 2280 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2011 | 2927 | 0.020 |
Why?
|
Proteins | 1 | 2020 | 6032 | 0.020 |
Why?
|
Inflammation | 1 | 2024 | 10774 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2010 | 1079 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16592 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3420 | 0.010 |
Why?
|
Genetic Markers | 1 | 2009 | 2601 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3442 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4111 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2735 | 0.010 |
Why?
|
Alleles | 1 | 2011 | 6864 | 0.010 |
Why?
|
Mental Health | 1 | 2014 | 3250 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2898 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2009 | 1421 | 0.010 |
Why?
|
Acute Disease | 1 | 2009 | 7237 | 0.010 |
Why?
|
Coronary Disease | 1 | 2011 | 5914 | 0.010 |
Why?
|
Genetic Testing | 1 | 2009 | 3537 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5799 | 0.010 |
Why?
|
Decision Making | 1 | 2009 | 3929 | 0.010 |
Why?
|
Child | 1 | 2022 | 80158 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 39969 | 0.010 |
Why?
|
Concepts
(251)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_